Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Bugianesi

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Biochemical Medicine|October 1, 1985
Targeting of synthetically glycosylated human placental glucocerebrosidaseG J Murray, T W Doebber, T Y Shen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1991
Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeysK L Thomson, M N Chang, R L Bugianesi, et al.
Biochemical and Biophysical Research Communications|February 15, 1988
(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonistM M Ponpipom, S B Hwang, T W Doebber, et al.
Journal of Medicinal Chemistry|September 18, 1992
Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate esterN N Girotra, T Biftu, M M Ponpipom, et al.
Journal of Medicinal Chemistry|November 11, 1994
Structure-activity relationships of C1 and C6 side chains of zaragozic acid A derivativesM M Ponpipom, N N Girotra, R L Bugianesi, et al.
Journal of Medicinal Chemistry|March 14, 1997
Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptidesC K Esser, R L Bugianesi, C G Caldwell, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Biochemical Medicine|October 1, 1985
Targeting of synthetically glycosylated human placental glucocerebrosidaseG J Murray, T W Doebber, T Y Shen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1991
Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeysK L Thomson, M N Chang, R L Bugianesi, et al.
Biochemical and Biophysical Research Communications|February 15, 1988
(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonistM M Ponpipom, S B Hwang, T W Doebber, et al.
Journal of Medicinal Chemistry|September 18, 1992
Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate esterN N Girotra, T Biftu, M M Ponpipom, et al.
Journal of Medicinal Chemistry|November 11, 1994
Structure-activity relationships of C1 and C6 side chains of zaragozic acid A derivativesM M Ponpipom, N N Girotra, R L Bugianesi, et al.
Journal of Medicinal Chemistry|March 14, 1997
Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptidesC K Esser, R L Bugianesi, C G Caldwell, et al.
Pageof 2